A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19
Luigi Aurisicchio, Nadia Brambilla, Marina Elena Cazzaniga, Paolo Bonfanti, Stefano Milleri, Paolo A. Ascierto, Serena Capici, Cristina Vitalini, Federica Girolami, Giampaolo Giacovelli, Gianfranco Caselli, Michela Visintin, Francesca Fanti, Matteo Ghirri, Antonella Conforti, Mirco Compagnone, Lucia Lione, Erika Salvatori, Eleonora Pinto, Alessia Muzi, Emanuele Marra, Fabio Palombo, Giuseppe Roscilli, Alessandro Manenti, Emanuele Montomoli, Matteo Cadossi, Lucio C. Rovati
Topics & Concepts
ImmunogenicityCoronavirus disease 2019 (COVID-19)Virology2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DNA vaccinationBiologyDNAMedicineImmunologyGeneticsImmune systemOutbreakInfectious disease (medical specialty)PlasmidInternal medicineDiseaseSARS-CoV-2 and COVID-19 ResearchViral Infections and Outbreaks ResearchVaccine Coverage and Hesitancy